Subscribe
ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
14 November 2017Americas

Federal Circuit reverses its earlier ruling in Life Technologies v Promega

The US Court of Appeals for the Federal Circuit has reversed its findings in Life Technologies v Promega, nine months after the US Supreme Court limited overseas patent infringement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
SCOTUS reverses Federal Circuit in Life Technologies v Promega
22 February 2017   The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.
Americas
Life v Promega reaction: SCOTUS raises more questions
23 February 2017   The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
SCOTUS reverses Federal Circuit in Life Technologies v Promega
22 February 2017   The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.
Americas
Life v Promega reaction: SCOTUS raises more questions
23 February 2017   The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.

More on this story

Americas
SCOTUS reverses Federal Circuit in Life Technologies v Promega
22 February 2017   The US Supreme Court today ruled that supplying a single component of a multi-component invention for manufacture abroad does not constitute patent infringement.
Americas
Life v Promega reaction: SCOTUS raises more questions
23 February 2017   The US Supreme Court has “left more questions than it answered” in the Life Technologies v Promega ruling, which was handed down yesterday, according to lawyers.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York